We would like to welcome Dr Twishi Gulati to Phenomics Australia’s team. Twishi brings an extensive experience in project design and business development strategy to our team. Her expertise will help us address an important capability gap for the research community, to benefit the health of all Australians.
The Phenomics Australia National Service Coordinator (In Vitro) will link key stakeholders funded through the NCRIS consortia with the platform facility teams and researchers who access the platforms to ensure engagement, sharing of technology development and education tools within the NCRIS network and beyond. This role is forward-thinking to ensure technology discussion and application and capturing the brightest researchers in the nation.
Meet Twishi
Dr Twishi Gulati has joined the Phenomics Australia team in the newly established National Service Coordinator (In Vitro) position. Since 2019, Twishi has been a Research Officer in the Victorian Centre for Functional Genomics (VCFG), a Phenomics Australia node at the Peter MacCallum Cancer Centre. There she managed the CRISPR screening platform, supporting researchers from project design through to experimentation and analysis. More recently, she has been involved in the VCFG’s business development strategy and managing the iLAB instrument access and billing system. Twishi has a PhD in proteomics, molecular and cellular biology from The University of Melbourne.
“ I am excited to join the Phenomics Australia team to bring Australia-wide infrastructure and expertise together to work collaboratively across our in vitro capabilities to ultimately drive better healthcare outcomes.”
Contact Twishi to know more about how we can help with your in vitro research.
Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers in vitro services through a collaborative consortium of ten laboratories and facilities across Australia.
